Testosterone injection - Lawley Pharmaceuticals

Drug Profile

Testosterone injection - Lawley Pharmaceuticals

Latest Information Update: 28 Jun 2016

Price : $50

At a glance

  • Originator Lawley Pharmaceuticals
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Alzheimer's disease

Most Recent Events

  • 28 Jun 2016 No development reported - Phase-II for Alzheimer's disease (In the elderly, Prevention) in Australia (IM) (ACTRN12613000034730)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top